Mathilde CHAMPEAU will defend her PhD thesis entitled "Dissolving microneedles for an optimal transdermal delivery of an active principle used in photodynamic therapy: Development and proof of [...]
Alexandre QUILBE will defend his thesis entitled "IN VITRO AND IN VIVO EVALUATION OF TWO NEW THERAPEUTIC STRATEGIES TARGETED IN PANCREATIC ADENOCARCINOMA: Immunotherapy targeting Immune Checkpoint [...]
Dr. Henri AZAIS, Surgeon - Gynecologist, defended his HDR (accreditation to direct research) on September 21, 2020
Dr. Henri AZAIS, defended on September 22 at the Faculty of Medicine of Lille, the accreditation to direct research (HDR). Much of his presentation focused on his research project at OncoThAI [...]
The meeting to set up the pilot, monocentric, descriptive, feasibility, safety and tolerance study of the BUBOLight® device "took place on September 14 at the Jeanne de Flandre Maternity Unit of the [...]
Visit of OncoThAi by an INSERM delegation chaired by Prof. Gilles BLOCH, Chairman and CEO of INSERM.
On September 3, 2020, OncoThAI had the honor to welcome, an INSERM delegation chaired by Prof. Gilles BLOCH, Chairman and CEO of INSERM.
Publication of French standard NF G20-030: Luminous textiles - Determination of the irradiance and luminance of luminous fabrics
French standard NF G20-030: Luminous textiles - Determination of the irradiance and luminance of luminous fabrics has just been published. OncoThAI, in particular, Elise THECUA, participated in [...]
Hemerion Therapeutics (www.hemerion.com), is a start-up spin-off from the OncoThAI laboratory (Pr. S. Mordon). Hemerion becomes the winner of the ILab 2020 French competition. Hemerion [...]
The article entitled "A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid" By Mathilde CHAMPEAU and al is now online. This project is performed thanks to a collaboration [...]
Page 1 of 10